雅虎香港 搜尋

搜尋結果

  1. 2024年4月30日 · If you have a larger lung cancer, chemotherapy or radiation therapy may be used before surgery to shrink the cancer. Chemotherapy or radiation therapy also may be used after surgery if there's a risk that cancer cells were left behind or that your cancer may come back.

  2. 2024年5月15日 · Forde PM, Spicer J, Lu S, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med 2022;386:1973-1985. Crossref PubMed ISI Google Scholar 5. Forde PM, Spicer J ...

  3. 6 天前 · Lee SM. Schulz C. Prabhash K. et al. First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. Lancet. 2023; 402: 451-463.

  4. 2024年5月9日 · Studies have demonstrated that NACT combined with surgical treatment plays a crucial role in improving the prognosis of patients with lung cancer. 21 And NACT and neoadjuvant radiotherapy as systemic have been recommended by the National Comprehensive

  5. 2 天前 · These clinical data suggest that tumors from lung cancer patients with poor survival rates or poor chemo-responses are characterized by a distinct immunosuppressive TME with a high level of ...

  6. 其他人也問了

  7. 2024年5月16日 · Abstract. Background: Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non-small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadjuvant therapy followed by surgery and adjuvant therapy) with nivolumab may further improve clinical outcomes.

  8. 2024年5月15日 · Neoadjuvant or Perioperative Approach in Lung Cancer. Authors: Marina Chiara Garassino, M.D., and Valter Torri, M.D. Author Info & Affiliations. Published May 15, 2024. N Engl J Med 2024;390:...